Following the cross-listing of RH Bophelo on the Rwanda Stock Exchange (RSE), the South Africa based investment company plans to raise financial resources, majority of which they say will be invested in Rwanda.
The Johannesburg Stock Exchange (JSE) listed healthcare group RH Bophelo's secondary listing on RSE officially came into effect on Monday June 1, making it the company's first evolution steps beyond South Africa.
The healthcare firm was Monday listed on the RSE by way of introduction, becoming the first South African healthcare company to cross list on the local bourse.
This means that the company's primary shares will be traded on the JSE but investors in Rwanda and in the wider East African region will have access to RH Bophelo's stocks through the Rwandan bourse.
In April, the firm's directors approved RH Bophelo's proposed secondary listing on the Rwanda Stock Exchange with the purpose to broaden the company's portfolio beyond South Africa.
